Zoetis has a total of 5008 patents globally, out of which 2859 have been granted. Of these 5008 patents, more than 61% patents are active. United States of America is where Zoetis has filed the maximum number of patents, followed by Europe and Australia. Parallelly, USA seems to be the main focused R&D center and is also the origin country of Zoetis.
Zoetis was founded in 1952. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. As of March 2022, Zoetis has a market cap of $89.83 Billion.
Do read about some of the most popular patents of Zoetis which have been covered by us in this article and also you can find Zoetis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Zoetis patent portfolio.
How many patents does the CEO of Zoetis have?
The CEO, Kristin C. Peck have 0 patents.
How many patents does Zoetis have?
Zoetis has a total of 5008 patents globally. These patents belong to 825 unique patent families. Out of 5008 patents, 3067 patents are active.
How Many Patents did Zoetis File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Zoetis Applications Filed | Zoetis Patents Granted |
| 2011 | 174 | 114 |
| 2012 | 393 | 122 |
| 2013 | 444 | 173 |
| 2014 | 441 | 133 |
| 2015 | 314 | 193 |
| 2016 | 287 | 246 |
| 2017 | 190 | 224 |
| 2018 | 218 | 217 |
| 2019 | 205 | 254 |
| 2020 | 92 | 185 |
| 2021 | 69 | 236 |
| 2022 | – | 44 |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
| Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
| US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
| US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
How many Zoetis patents are Alive/Dead?
Worldwide Patents
Patent Families
How Many Patents did Zoetis File in Different Countries?
Countries in which Zoetis Filed Patents
| Country | Patents |
| United States Of America | 646 |
| Europe | 365 |
| Australia | 360 |
| Canada | 317 |
| China | 278 |
| Japan | 256 |
| Germany | 236 |
| Brazil | 211 |
| Korea (South) | 159 |
| Hong Kong (S.A.R.) | 159 |
| Mexico | 148 |
| New Zealand | 144 |
| Denmark | 126 |
| Spain | 122 |
| Russia | 98 |
| Taiwan | 92 |
| Poland | 82 |
| South Africa | 80 |
| Chile | 71 |
| Philippines | 65 |
| Portugal | 59 |
| Slovenia | 54 |
| Argentina | 53 |
| India | 52 |
| Hungary | 43 |
| Croatia | 39 |
| Austria | 38 |
| Israel | 38 |
| United Kingdom | 37 |
| Indonesia | 32 |
| Singapore | 26 |
| Montenegro | 24 |
| Cyprus | 23 |
| Norway | 22 |
| Lithuania | 22 |
| Colombia | 21 |
| Malaysia | 18 |
| Serbia | 17 |
| Uruguay | 11 |
| Viet Nam | 10 |
| Czech Republic | 9 |
| Turkey | 8 |
| Slovakia | 7 |
| Peru | 6 |
| Ukraine | 5 |
| Luxembourg | 4 |
| Belgium | 4 |
| Costa Rica | 4 |
| Nicaragua | 3 |
| Belarus | 3 |
| Tunisia | 2 |
| France | 2 |
| Sweden | 2 |
| Morocco | 1 |
| Iceland | 1 |
| Finland | 1 |
| Netherlands | 1 |
| Saudi Arabia | 1 |
| Africa | 1 |
| Macao | 1 |
| Botswana | 1 |
| Bulgaria | 1 |
| Eurasia | 1 |
| Ireland | 1 |
Where are Research Centers of Zoetis Patents Located?
10 Best Zoetis Patents
US6395765B1 is the most popular patent in the Zoetis portfolio. It has received 257 citations so far from companies like Pfizer, Bayer Cropscience and Boehringer Ingelheim.
Below is the list of 10 most cited patents of Zoetis:
| Publication Number | Citation Count |
| US6395765B1 | 257 |
| US6703023B1 | 241 |
| US6610310B2 | 131 |
| US6500662B1 | 129 |
| WO2004026283A1 | 125 |
| US6601534B2 | 124 |
| US7018638B2 | 116 |
| WO2014036056A1 | 113 |
| US7169394B2 | 112 |
| US7223594B2 | 102 |
Which Companies are using Zoetis Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Zoetis patent portfolio are Boehringer Ingelheim Vetmedica Inc, Intervet Inc and Boehringer Ingelheim Animal Health Usa Inc.
List of the top forward citing Companies –
| Company | Number of Patents |
| Boehringer Ingelheim Vetmedica Inc | 21 |
| Intervet Inc | 11 |
| Boehringer Ingelheim Animal Health Usa Inc | 10 |
| Gearbox Llc | 5 |
| Merial Inc | 4 |
| Novartis | 3 |
| Samsung Electronics | 3 |
| Pulike Biological Engineering Inc | 3 |
| Virginia Tech Intellectual Properties Inc | 3 |
| Dow Agrosciences | 3 |
Count of 102 and 103 Type Rejections based on Zoetis Patents
Top Zoetis Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US6703023B1 | 14 |
| US7223407B2 | 12 |
| US6395765B1 | 11 |
| US7294355B2 | 10 |
| US8097614B2 | 9 |
| US8377643B2 | 8 |
| US20040096548A1 | 7 |
| US7828765B2 | 6 |
| US7722884B2 | 5 |
| US7153513B2 | 5 |
| US6535277B2 | 5 |
| US7041439B2 | 5 |
| US7223594B2 | 4 |
| US6601534B2 | 4 |
| US9034656B2 | 4 |
What Percentage of Zoetis US Patent Applications were Granted?
Zoetis (Excluding its subsidiaries) has filed 214 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 172 have been granted leading to a grant rate of 85.15%.
Below are the key stats of Zoetis patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Zoetis?
| Law Firm | Total Applications | Success Rate |
| Zoetis | 166 | 83.54% |
| Pfizer Inc | 18 | 88.24% |
| Gregg C Benson | 3 | 100.00% |
| Paul H Ginsburg | 5 | 100.00% |
| Dr Peter C Richardson | 2 | 100.00% |
| Haug Partners Llp | 2 | 100.00% |
| Karen A Magri | 2 | 100.00% |
| Paul D Bianco | 2 | 100.00% |
| J Charles Dougherty | 1 | 100.00% |
| Jones Day For Celgene Corporation | 1 | 0% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Zoetis’s key innovation segments?